DFX9006SC: Bard Distaflo Mini Cuff Bypass Graft: Flex Small Beading, Carbon 6mm x 90cm

Sign in to add this product to your favorites!
| Price: | $1,799.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 05-2028 |
Additional Details
Distaflo® Mini Bypass Graft
Mini-Cuff, Flex Small Bead
- Designed to provide optimal hemodynamics in below-the-knee, small target arteries with low flow rates
- Tapered distal end increases flow velocity and allows the cuff to produce a vortex for adequate wall shear stress throughout the anastomosis
- Proven to perform as well as ePTFE with a vein cuff in below-the-knee bypass procedures
AccessGUDID Info
- FDA Product Code: DSY
- FDA Product Code Name: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
- FDA Product Code: DYF
- FDA Product Code Name: PROSTHESIS, VASCULAR GRAFT, OF LESS THEN 6MM DIAMETER
- GMDN Term Code: 35281
- GMDN Term Name: Synthetic vascular graft
- GMDN Term Description: An implantable artificial substitute for a blood vessel intended to replace or bypass the diseased or injured vessel. It is typically made of woven or knitted polyethylene terephthalate (Dacron) or polytetrafluoroethylene (PTFE) fabrics and is best suited for large (more than 10 mm) diameter, high-flow vessel replacement (e.g., aortic or aorto-iliac artery reconstruction) and also for haemodialysis access and extra-anatomic bypass grafting. The device is used in many vascular bypass procedures (e.g., aorto-iliac, femoral-popliteal, axillo-axillary artery) except those involving the coronary arteries.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE